Last Price Today's Change   Day's Range   Trading Volume
141.36   -1.36 (0.95%)  141.00 - 142.57  197,458


Avg Volume (4 weeks):1,068,965
4 Weeks Range:129.11 - 145.00
4 Weeks Price Volatility (%):
52 Weeks Range:91.62 - 145.00
52 Weeks Price Volatility (%):
Average Price Target: 88.00
Price Target Upside/Downside: -53.36


No recent Headlines for this stock.

Business Background

CSL Limited is a biotherapeutics company that develops and delivers biotherapies. The Company's principal activities are research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. Its segments include CSL Behring, Seqirus and CSL Intellectual Property. The CSL Behring segment manufactures, markets and develops plasma therapies (plasma products and recombinants). The Seqirus segment manufactures and distributes non-plasma biotherapeutic products. Seqirus manufactures, sells and distributes a range of vaccines, antivenoms and other pharmaceutical products in Australia and New Zealand. It also manufactures and markets in vitro diagnostic products through Seqirus immunohematology. The CSL Intellectual Property segment is engaged in licensing of intellectual property generated by the Company to unrelated third parties. The Company has facilities in Australia, Germany, Switzerland, the United Kingdom and the United States.

  Be the first to like this.


255  434  751  9619 

Top 10 Active Counters
 IIL 0.057-0.583 
 CMY 0.005-0.001 
 88E 0.051+0.005 
 EUC 0.087+0.004 
 THD 0.0110.00 
 ICG 0.011-0.001 
 TV2 0.017+0.002 
 AGO 0.0120.00 
 CGM 0.0090.00 
 BUB 0.285-0.005 
Partners & Brokers